购物车
- 全部删除
- 您的购物车当前为空
UTL-5g (3-Isoxazolecarboxamide, N-(2,4-dichlorophenyl)-5-methyl-) 是一种抗炎性TNF-α抑制剂,可通过抑制 TNF-α 等因子降低顺铂引起的肝毒性、肾毒性和骨髓毒性,具有化学保护和肝脏放射保护作用。
为众多的药物研发团队赋能,
让新药发现更简单!
UTL-5g (3-Isoxazolecarboxamide, N-(2,4-dichlorophenyl)-5-methyl-) 是一种抗炎性TNF-α抑制剂,可通过抑制 TNF-α 等因子降低顺铂引起的肝毒性、肾毒性和骨髓毒性,具有化学保护和肝脏放射保护作用。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 622 | 现货 | |
5 mg | ¥ 1,490 | 现货 | |
10 mg | ¥ 2,320 | 现货 | |
25 mg | ¥ 4,000 | 现货 | |
50 mg | ¥ 5,680 | 现货 | |
100 mg | ¥ 7,950 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 2,360 | 现货 |
产品描述 | UTL-5g (3-Isoxazolecarboxamide, N-(2,4-dichlorophenyl)-5-methyl-) is a novel potential chemoprotective agent, TNF-α inhibitor that reduces cisplatin-induced side effects including nephrotoxicity, hepatotoxicity and hematotoxicity. It lowers elevated levels of AST, ALT, creatinine, BUN, and TNF-α, increases the reduced platelet count in mice, and acts as a novel chemo- and radioprotective agent. |
体内活性 | UTL-5g (GBL-5g) 通过降低由肺部照射引起的TGF-β 和TNF-α 水平[1]。 |
别名 | GBL-5g, 3-Isoxazolecarboxamide, N-(2,4-dichlorophenyl)-5-methyl- |
分子量 | 271.1 |
分子式 | C11H8Cl2N2O2 |
CAS No. | 646530-37-2 |
Smiles | Cc1cc(no1)C(=O)Nc1ccc(Cl)cc1Cl |
密度 | 1.469 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 27.5 mg/mL (101.44 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容